|
Memantine Clinical Trials
7 actively recruiting trials across 6 locations
▲ +1 trial since June 2026
Also known as: Namenda, Namenda XR, Namenda XR Titration Pack
Pipeline
Early 1: 1Phase 2: 4Phase 3: 1Phase 1/2: 1
Top Sponsors
- University of Zurich1
- UNC Lineberger Comprehensive Cancer Center1
- Mclean Hospital1
- Massachusetts General Hospital1
- Duke University1
Indications
- Cancer5
- Brain Metastases3
- Major Depression1
- Alzheimer's Disease1
- Osteoporosis1
Other1 trial
Phase 1/2
Tucson, Arizona1 trial
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
University of Arizona Cancer Center-Orange Grove Campus
Phase 3
Belmont, Massachusetts1 trial
Early 1
Boston, Massachusetts1 trial
NTS-WBRT in Brain Metastases
Massachusetts General Hospital Cancer Center
Phase 2
Chapel Hill, North Carolina1 trial
Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill
Phase 2
Durham, North Carolina1 trial
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
Duke Memory Disorders Clinic
Phase 2
Cleveland, Ohio1 trial
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.